UPDATE 1-Norway's PCI Biotech sees promising data from cancer drug study - CEO [Reuters]
RXI PHARMACEUTICALS CORP (RXII)
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.rxipharma.com
Company Research
Source: Reuters
UPDATE 1-Norway's PCI Biotech sees promising data from cancer drug study - CEO | Reuters Reuters Staff 3 Min Read * PCI develops fimaCHEM bile duct cancer drug treatment * Pivotal second-phase study to start in H2 * Needs extra capital or partnership to finish study * Brokerage Arctic predicts revenues from 2022 (Adds quotes, background, bullets) By Camilla Knudsen OSLO, April 24 (Reuters) - Norwegian drug maker PCI Biotech has seen promising results from its bile duct cancer study ahead of a key second phase, but will need extra capital or a partnership to finalise a treatment, its chief executive told Reuters. Developing the fimaCHEM platform, combining light-based, photochemical technology with its fimaporfin drug, PCI seeks to treat patients who have inoperable tumours. “We are currently in an extension of phase one, scheduled to be finished in the second half of 2018, and then we are ready to start the pivotal phase two almost immediately,” Chief Executive Per Walday said in an i
Show less
Read more
Impact Snapshot
Event Time:
RXII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXII alerts
High impacting RXI PHARMACEUTICALS CORP news events
Weekly update
A roundup of the hottest topics